quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:18:23·167d
SECFiling
Exicure Inc. logo

SEC Form 10-Q filed by Exicure Inc.

XCUR· Exicure Inc.
Health Care
Original source

Companies

  • XCUR
    Exicure Inc.
    Health Care

Recent analyst ratings

  • Dec 13UpdateChardan Capital Markets$0.40
  • Nov 23UpdateChardan Capital$2.25

Related

  • PR1d
    Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
  • SEC13d
    Exicure Inc. filed SEC Form 8-K: Leadership Update
  • SEC21d
    Exicure Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC27d
    Exicure Inc. filed SEC Form 8-K: Leadership Update
  • SEC29d
    SEC Form 10-K filed by Exicure Inc.
  • SEC29d
    Exicure Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR29d
    Exicure, Inc. Reports Full Year 2025 Financial Results
  • INSIDER63d
    Chief Accounting Officer Miller Josh covered exercise/tax liability with 8 shares, decreasing direct ownership by 3% to 301 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022